The importance of racial diversity in clinical trials
https://www.facingourrisk.org/XRAY/racial-diversity-in-cancer-drug-clinical-trials
Full article: https://www.propublica.org/article/black-patients-miss-out-on-promising-cancer-drugs
This article by journalists Caroline Chen and Riley Wong looks at racial disparities between participation in clinical trials and the population of people with cancer. (11/6/18)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- Do I qualify for any clinical trials that are currently enrolling?
- What are the risks and benefits of participating in a clinical trial?
- What is known about the cancer drugs I am taking for people with my racial or ethnic background?
Open Clinical Trials
The following clinical research studies focus on addressing health disparities in cancer.
- NCT04854304: Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts. This study is looking at how effectively a FAST breast MRI can successfully detect breast cancer in Black women with dense breasts.
- NCT03640208: Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African Americans. This research will study a community-based intervention to educate and overcome barriers to screening among African Americans who are 45 years or older with no personal or family history of colorectal cancer or inflammatory bowel disease.
- NCT04392050: A Community-Based Educational Intervention to Improve Colorectal Cancer Screening. This study will look at what makes it easy or difficult for underserved populations to have colorectal cancer screenings, with a focus on African American, Latinx and Asian people.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.